Internal Medicine, Gastroenterology · Atlanta, GA
NPI
1588649693
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
5671 Peachtree Dunwoody Rd NE, Suite 600
Atlanta, GA, 30342
Phone (404) 257-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
2,150 services
Medicare patients, 2024
111
Average age 73
Drug cost, 2024
$8.0M
958 prescriptions
Company payments, 2025
$99K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas C Wolf was code 99215 (office e&m - established), 136 times for 76 patients. In total Douglas C Wolf billed 2,150 services in 22 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 136 | 76 | $130.83 | $18K |
| 45380 Lower GI Endoscopy - Other | Facility | 29 | 29 | $152.22 | $4,414 |
| 43239 Upper GI Endoscopy | Facility | 28 | 26 | $72.18 | $2,021 |
| 99214 Office E&M - Established | Office | 28 | 27 | $90.19 | $2,525 |
By year: 2022 $95K for 5,706 services; 2023 $94K for 4,454 services; 2024 $74K for 2,150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas C Wolf prescribed most often to Medicare patients was Stelara (Ustekinumab), with 241 prescriptions and refills. In total Douglas C Wolf wrote 958 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 241 | 334 | 32 | $6.6M |
| Omeprazole Generic | 145 | 382 | 46 | $1,193 |
| Mesalamine Generic | 69 | 132 | 16 | $66K |
| Azathioprine Generic | 49 | 107 | Under 11 | $1,151 |
| Humira(Cf) Pen Adalimumab | 46 | 53 | Under 11 | $699K |
| Prednisone Generic | 36 | 48 | 15 | $358 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 29 | 33 | Under 11 | $942 |
| Ondansetron Hcl Generic | 25 | 32 | 15 | $515 |
| Metronidazole Generic | 20 | 28 | Under 11 | $332 |
| Ondansetron Odt Ondansetron | 20 | 30 | Under 11 | $275 |
| Colesevelam Hcl Generic | 20 | 26 | Under 11 | $3,258 |
| Dicyclomine Hcl Generic | 19 | 30 | Under 11 | $566 |
| Skyrizi On-Body Risankizumab-Rzaa | 14 | 26 | Under 11 | $287K |
| Loperamide Loperamide Hcl | 13 | 15 | Under 11 | $334 |
| Xifaxan Rifaximin | 13 | 13 | Under 11 | $41K |
Brand drugs: - claims; generic drugs: 565 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas C Wolf $99K ($99K in general payments such as food, travel and fees) from 16 companies. The largest payer was Janssen Biotech, Inc. with $57K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 39 | $57K |
| Abbvie Inc. ABBV | 48 | $39K |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $2,367 |
| Pfizer Inc. PFE | 12 | $144 |
| Madrigal Pharmaceuticals MDGL | 4 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $112 |
| Celltrion USA Inc. 068270.KS | 5 | $110 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 5 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $73.55 |
| Lilly USA, LLC LLY | 2 | $49.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.